Te­va re­port­ed­ly con­sid­er­ing sale of API unit

Te­va is re­port­ed­ly con­sid­er­ing a sale of its ac­tive phar­ma­ceu­ti­cal in­gre­di­ents busi­ness amid a wider strate­gic shift for the com­pa­ny.

The Is­raeli drug­mak­er has hired …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER